AN 2728 in paediatric and adolescent patients with atopic dermatitis: MUSE trial.

Trial Profile

AN 2728 in paediatric and adolescent patients with atopic dermatitis: MUSE trial.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs Crisaborole (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms MUSE
  • Most Recent Events

    • 19 Oct 2015 According to Leo Pharma media release, the US FDA has approved Enstilar for the treatment of plaque psoriasis.
    • 13 Nov 2013 New trial record
    • 12 Nov 2013 Interim results reported in an Anacor Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top